Kajian klinikal Katarak di Texas
7 kajian untuk Katarak sedang mencari peserta di lokasi di Texas.
Bandar di Texas
Teks kajian rasmi (Bahasa Inggeris)
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
- Berkeley Eye Center, Houston
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
Umur 40 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06922084A Prospective, Randomized, Subject- and Examiner-Masked, Multicenter Study Comparing Bilateral Clareon TruPlus and Bilateral Clareon Monofocal Intraocular Lens Implantation (Spherical and Toric) in Cataract Subjects
- Berkeley Eye Center - Sugar Land, Sugar Land
Mengambil pesertaFasa 4
Umur 22 ke atas · Semua jantina · Dikemas kini 21 Jul 2026 · NCT07693205Clareon TruPlus Study
- Berkeley Eye Center, Sugar Land
Mengambil peserta
Umur 22 ke atas · Semua jantina · Dikemas kini 3 Jun 2026 · NCT07502456IC-8 Apthera IOL New Enrollment Post Approval Study
- Berkeley Eye Center, Sugar Land
Mengambil pesertaKajian pemerhatian
Umur 22 ke atas · Semua jantina · Dikemas kini 12 Jan 2026 · NCT06060041Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
- R and R Eye Research, LLC, San Antonio
Mengambil pesertaFasa 3
Umur 22 ke atas · Semua jantina · Dikemas kini 20 Okt 2025 · NCT07218796Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
- Houston Eye Associates, Houston
Mengambil pesertaFasa 3
Umur 22 ke atas · Semua jantina · Dikemas kini 20 Okt 2025 · NCT07218783Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Methodist Eye Associates | Houston Methodist, Houston
Mengambil peserta
Umur 65 ke atas · Semua jantina · Dikemas kini 3 Dis 2024 · NCT05438732Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.